Andexanet Alfa Use in Cardiac Surgical Patients: A Xa Inhibitor and Heparin Reversal Agent.
Publication
, Journal Article
Levy, JH; Connors, JM
Published in: J Cardiothorac Vasc Anesth
January 2021
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Cardiothorac Vasc Anesth
DOI
EISSN
1532-8422
Publication Date
January 2021
Volume
35
Issue
1
Start / End Page
265 / 266
Location
United States
Related Subject Headings
- Recombinant Proteins
- Pyridones
- Pyrazoles
- Off-Label Use
- Humans
- Heparin
- Factor Xa
- Extracorporeal Membrane Oxygenation
- Aortic Dissection
- Anesthesiology
Citation
APA
Chicago
ICMJE
MLA
NLM
Levy, J. H., & Connors, J. M. (2021). Andexanet Alfa Use in Cardiac Surgical Patients: A Xa Inhibitor and Heparin Reversal Agent. J Cardiothorac Vasc Anesth, 35(1), 265–266. https://doi.org/10.1053/j.jvca.2020.09.091
Levy, Jerrold H., and Jean M. Connors. “Andexanet Alfa Use in Cardiac Surgical Patients: A Xa Inhibitor and Heparin Reversal Agent.” J Cardiothorac Vasc Anesth 35, no. 1 (January 2021): 265–66. https://doi.org/10.1053/j.jvca.2020.09.091.
Levy JH, Connors JM. Andexanet Alfa Use in Cardiac Surgical Patients: A Xa Inhibitor and Heparin Reversal Agent. J Cardiothorac Vasc Anesth. 2021 Jan;35(1):265–6.
Levy, Jerrold H., and Jean M. Connors. “Andexanet Alfa Use in Cardiac Surgical Patients: A Xa Inhibitor and Heparin Reversal Agent.” J Cardiothorac Vasc Anesth, vol. 35, no. 1, Jan. 2021, pp. 265–66. Pubmed, doi:10.1053/j.jvca.2020.09.091.
Levy JH, Connors JM. Andexanet Alfa Use in Cardiac Surgical Patients: A Xa Inhibitor and Heparin Reversal Agent. J Cardiothorac Vasc Anesth. 2021 Jan;35(1):265–266.
Published In
J Cardiothorac Vasc Anesth
DOI
EISSN
1532-8422
Publication Date
January 2021
Volume
35
Issue
1
Start / End Page
265 / 266
Location
United States
Related Subject Headings
- Recombinant Proteins
- Pyridones
- Pyrazoles
- Off-Label Use
- Humans
- Heparin
- Factor Xa
- Extracorporeal Membrane Oxygenation
- Aortic Dissection
- Anesthesiology